Viral hepatitis amidst COVID-19 in Africa: Implications and recommendations

Syeda Kanza Kazmi1, Fatima Muhammad Asad Khan1, Valentino Natoli2

  • 1Department of General Medicine, Dow University of Health Sciences, Karachi, Pakistan.

Journal of Medical Virology
|September 10, 2021
PubMed

Insights

Hepatitis B and C affect nearly 100 million people in Africa, straining healthcare systems already burdened by COVID-19. Enhanced prevention policies are crucial for Africa

Area of Science:

  • Hepatology and Infectious Diseases
  • Global Public Health

Background:

  • Hepatitis B and C are major global health concerns, causing significant mortality.
  • Africa faces a substantial burden, with an estimated 100 million individuals infected with Hepatitis B or C.
  • The COVID-19 pandemic exacerbates existing health challenges in Africa, potentially overwhelming healthcare systems.

Purpose of the Study:

  • To highlight the prevalence of Hepatitis B and C in Africa.
  • To underscore the compounded threat of viral hepatitis amidst the COVID-19 pandemic.
  • To advocate for strengthened prevention strategies in Africa.

Main Methods:

  • Review of global and continental Hepatitis prevalence data.
  • Analysis of the impact of COVID-19 on African healthcare infrastructure.
  • Assessment of existing public health challenges related to viral infections.

Main Results:

  • Hepatitis B and C impact approximately 100 million people across Africa.
  • Egypt, Cameroon, and Burundi show the highest prevalence rates.
  • Viral diseases like Hepatitis pose a significant risk to fragile healthcare systems, especially during pandemics.

Conclusions:

  • Urgent implementation of enhanced prevention policies is necessary for Africa.
  • Strengthening public health resilience against viral hepatitis is critical.
  • Addressing Hepatitis is vital for mitigating mortality and healthcare system collapse in Africa.